Chronic Coronary Artery Disease

Area of Science:

• Cardiology
• Vascular Biology
• Metabolic Medicine

Background:

• Chronic coronary artery disease (CCAD) is a significant global health burden, primarily caused by myocardial metabolic demand exceeding oxygen supply due to coronary artery atherosclerosis.
• The clinical manifestation of CCAD, typically angina, shows considerable patient-to-patient variability.
• The pathophysiology involves an imbalance between the heart's energy needs and its oxygen delivery, predominantly driven by atherosclerosis.

Purpose of the Study:

• To provide an updated overview of chronic coronary artery disease (CCAD).
• To highlight recent advancements in therapeutic options for managing CCAD.
• To discuss the evolving understanding of CCAD pathobiology and clinical presentation.

Main Methods:

• Literature review of recent studies and clinical trials.
• Analysis of newly approved pharmacological interventions for CCAD.
• Synthesis of current clinical guidelines and expert consensus.

Main Results:

• Several new medications have been approved since 2019 to mitigate ischemic events in CCAD patients.
• Advances in understanding CCAD pathophysiology continue to emerge.
• Recognition of diverse clinical presentations beyond classic angina.

Conclusions:

• CCAD remains a critical area of cardiovascular medicine requiring ongoing research and clinical attention.
• Newly available medications offer improved strategies for managing CCAD and reducing ischemic complications.
• A comprehensive approach considering pathobiology and varied clinical presentations is essential for effective CCAD patient care.